Search Results

feels familiar: timelines stretched, BD slowed, the board wants “one more layer of clarity,” and your team visible enough that you can’t ignore it. ✅ That’s the real leadership test, not how you motivate the team Why This Is Dangerous (and Expensive) 👉 Biotech teams usually believe the cost of leadership drift is investor trust:   Updates feel inconsistent, story arcs keep mutating Confused operating rhythms:   Teams drafts instead of decisions Your “platform vs. asset company” identity is still vague by mid-year The team